Matthew Breite, MD
Vascular Surgery · Saint Louis, MONPI 1114373941
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (42.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 43.3% of the total. Reporting peaked in 2022 at $3,528 and has fallen 89.8% since, to $358 in 2025.
Across 45 payments — averaging $177.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Silk Road Medical, Inc.$1K
- W. L. Gore & Associates, Inc.$1K
- Cook Medical LLC$616
- Shockwave Medical, Inc$506
- Penumbra, Inc.$146
- plus $465 from 12 others
What the payments were for
- Grants$3,41743%
- Travel & lodging$1,66321%
- Food & beverage$2,60833%
- Education$3014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $3,463 |
| Silk Road Medical, Inc. | 8 | $1,398 |
| W. L. Gore & Associates, Inc. | 9 | $1,395 |
| Cook Medical LLC | 8 | $616 |
| Shockwave Medical, Inc | 3 | $506 |
| Penumbra, Inc. | 1 | $146 |
| Abbott | 1 | $135 |
| Boston Scientific | 1 | $71 |
| Angiodynamics, Inc. | 1 | $48 |
| Cvrx, Inc. | 1 | $39 |
| Bolton Medical Inc | 1 | $30 |
| Davol Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $20 |
| Kerecis Limited | 1 | $18 |
| Ossur Americas, Inc. | 1 | $16 |
| Solventum Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$3,417
- ENROUTE Transcarotid Neuroprotection System$1,747
- ENROUTE Transcarotid Stent$1,354
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,007
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$479
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$393
- GORE EXCLUDER AAA Endoprosthesis$171
- Indigo System$146
- JETI$135
- Zenith Alpha$111
- Zilver PTX$105
How this compares
$7,989 in reported general payments places this provider in the 60th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 43 | $628 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Saint Louis
- Jeffrey JimSaint Louis$1.2M
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Patrick GeraghtySaint Louis$65K
- Nathan DrozSaint Louis$38K
- Mohamed ZayedSaint Louis$30K
- Vipul KhetarpaulSaint Louis$23K
- Zachary WankenSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.